As RSV cases tick up, CDC warns that a key drug to keep babies safe is in short supply

The CDC issued an alert to doctors about a shortage of certain doses of an RSV antibody drug Beyfortus given to newborns and infants to prevent RSV. Certain dosages are limited.

Related Keywords

Vanderbilt University ,Tennessee ,United States , ,Vanderbilt University Medical Center ,Drug Administration ,Centers For Disease ,Disease Control ,Buddy Creech ,Rsv Infection ,Rsv Season ,Limited Availability ,Rsv Vaccine ,Pediatric Infectious Disease ,Limited Supply ,Enters For Disease Control And Prevention ,Newly Approved ,Food And Drug Administration ,